GlobeNewswire 01-08 Recludix Pharma Bolsters Scientific Advisory Board with Acclaimed Leaders in the Fields of Rheumatol...
GlobeNewswire 01-08 MoonLake Immunotherapeutics Announces Positive Outcome from Type B Meeting with U.S. FDA and Announc...
GlobeNewswire 01-08 Alveus Therapeutics Launches with $160 Million Series A Financing to Advance Next-Generation Therapi...
GlobeNewswire 01-08 Diagonal Therapeutics Announces Oversubscribed $125 Million Series B Financing to Advance Clinical D...
GlobeNewswire 01-07 BrightInsight’s Patient App, developed with Sanofi, shows positive impact in patient treatment adher...
GlobeNewswire 01-07 Vaxxas Appoints Former Merck Global Vaccines President David Peacock as CEO
GlobeNewswire 01-07 Recludix Pharma to Present at the Annual J.P. Morgan Healthcare Conference
GlobeNewswire 01-07 SAB BIO Strengthens Board of Directors with Appointment of New Chair and New Director
GlobeNewswire 01-06 Halper Sadeh LLC Encourages DVAX, FONR, DBRG, ONTF Shareholders to Contact the Firm to Discuss Their...
GlobeNewswire 01-06 $HAREHOLDER ALERT: The M&A Class Action Firm Is Investigating the Merger—DVAX, FONR, DBRG, and ONTF
GlobeNewswire 01-06 Denali Therapeutics Announces Key Anticipated Milestones and Priorities for 2026 Including Commercia...
GlobeNewswire 01-06 NodThera Announces Presentation at the 44th Annual J.P. Morgan Healthcare Conference
GlobeNewswire 01-06 Enable Injections Announces $30 Million Investment from Sanofi to Accelerate Manufacturing Capabilit...
GlobeNewswire 01-05 Compass Therapeutics Announces Key Leadership Appointments
GlobeNewswire 01-05 ElevateBio Appoints Christopher Murphy as Chief Executive Officer and Member of the Board of Directo...
GlobeNewswire 01-05 Nurix Therapeutics to Participate in the 44th Annual J.P. Morgan Healthcare Conference
GlobeNewswire 01-05 Press Release: Sanofi’s Tzield accepted for priority review in the US for young children with stage ...
GlobeNewswire 2025-12-29 Tonix Pharmaceuticals Announces Program Updates on Phase 2/3-Ready Long-Acting Monoclonal Antibody (...
TeleTrader 2025-12-29 Europe mostly higher at open, Ukraine in limelight
TeleTrader 2025-12-24 Dynavax jumps 37% on Sanofi acquisition
TeleTrader 2025-12-24 Sanofi to acquire Dynavax for $2.2B
GlobeNewswire 2025-12-24 Press Release: Sanofi to acquire Dynavax, adding a marketed adult hepatitis B vaccine and phase 1/2 ...
GlobeNewswire 2025-12-24 Press Release: Sanofi provides update on tolebrutinib regulatory submission in non-relapsing seconda...
TeleTrader 2025-12-23 Europe ends mostly higher, focus on pharma
TeleTrader 2025-12-23 Sanofi wins EU approval for Wayrilz drug